Literature DB >> 6289297

Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells.

D W Coalson, J O Mecham, P H Stern, R M Hoffman.   

Abstract

Methionine (Met) dependence--i.e., the inability of cultured cells to grow when Met is replaced by its immediate precursor homocysteine (Met-Hcy+ medium)--is a frequent component of the oncogenically transformed phenotype. Normal cells, on the other hand, grow in this medium. There have been reports [Hoffman, R. M. & Erbe, R. W. (1976) Proc. Natl. Acad. Sci. USA 73, 1523-1527; Hoffman, R. M., Jacobsen, S. J. & Erbe, R. W. (1978) Biochem. Biophys. Res. Commun. 82, 228-234] of normal or higher rats of Met biosynthesis in Met-dependent cells and a postulation that Met-dependent cells are deficient in utilization of endogenously synthesized Met as opposed to exogenously supplied Met. To answer the critical question of what biochemical reaction(s) requires preformed Met in Met-dependent cels, we labeled cells with Met-free [35S]Hcy or [35S]Met and determined the levels of Met, S-adenosylmethionine (AdoMet), and S-adenosylhomocysteine (AdoHcy). We report here experiments that demonstrate that Met-dependent cells synthesize a normal amount of endogenously synthesized Met and are deficient in utilizing this Met for AdoMet synthesis. In contrast, exogenously supplied Met is utilized normally for AdoMet biosynthesis. The ratio of AdoMet to AdoHcy is low in Met-dependent cells growing in Met-Hcy+ medium but is normal in Met+Hcy- medium. We determined that the low AdoMet/AdoHcy ratio probably limits growth of Met-dependent cells in Met-Hcy+ medium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289297      PMCID: PMC346647          DOI: 10.1073/pnas.79.14.4248

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation.

Authors:  R M Hoffman; S J Jacobsen; R W Erbe
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

2.  3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells.

Authors:  J P Bader; N R Brown; P K Chiang; G L Cantoni
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

3.  Reversion to methionine independence by malignant rat and SV40-transformed human fibroblasts.

Authors:  R M Hoffman; S J Jacobsen; R W Erbe
Journal:  Biochem Biophys Res Commun       Date:  1978-05-15       Impact factor: 3.575

4.  Tumor therapy by deprivation of L-methionine: rationale and results.

Authors:  W Kreis
Journal:  Cancer Treat Rep       Date:  1979-06

5.  Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo.

Authors:  P K Chiang; G L Cantoni
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

6.  Dependence of 5-methyltetrahydrofolate utilization by L5178Y murine leukemia cells in vitro on the presence of hydroxycobalamin and transcobalamin II.

Authors:  P L Chello; J R Bertino
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

7.  High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine.

Authors:  R M Hoffman; R W Erbe
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

8.  Changes in tRNA methyltransferase activity and cellular S-adenosylmethionine content following methionine deprivation.

Authors:  M J Tisdale
Journal:  Biochim Biophys Acta       Date:  1980-09-19

9.  The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture.

Authors:  B C Halpern; B R Clark; D N Hardy; R M Halpern; R A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells.

Authors:  W Kreis; M Goodenow
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

View more
  30 in total

1.  Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Authors:  Kei Kawaguchi; Kentaro Miyake; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Thinzar M Lwin; Takashi Higuchi; Tasuku Kiyuna; Masuyo Miyake; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

2.  Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Mark A Eckardt; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

Review 3.  The wayward methyl group and the cascade to cancer.

Authors:  Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

4.  Methylthioadenosine toxicity and metabolism to methionine in mammalian cells.

Authors:  L Christa; J Kersual; J Augé; J L Pérignon
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

5.  Unchecked DNA synthesis and blocked cell division induced by methionine deprivation in a human prostate cancer cell line.

Authors:  H Y Guo; R M Hoffman; H Herrera
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

6.  Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.

Authors:  Shuya Yano; Kiyoto Takehara; Ming Zhao; Yuying Tan; Qinghong Han; Shukuan Li; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

7.  Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Shukuan Li; Qinghong Han; Yuying Tan; Ming Zhao; Yunfeng Li; Scott D Nelson; Sarah M Dry; Arun S Singh; Irmina A Elliott; Tara A Russell; Mark A Eckardt; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

8.  Elevated overall rates of transmethylation in cell lines from diverse human tumors.

Authors:  P H Stern; R M Hoffman
Journal:  In Vitro       Date:  1984-08

9.  Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer.

Authors:  Hye In Lim; Kazuyuki Hamada; Jun Yamamoto; Qinhong Han; Yuying Tan; Hee Jun Choi; Seok Jin Nam; Michael Bouvet; Robert M Hoffman
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  Association of SIBA treatment and a Met-depleted diet inhibits in vitro growth and in vivo metastatic spread of experimental tumor cell lines.

Authors:  F Breillout; M F Poupon; P Blanchard; V Lascaux; P Echinard-Garin; M Robert-Gero
Journal:  Clin Exp Metastasis       Date:  1988 Jan-Feb       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.